MediXall Group, Inc.
MDXL
$0.0001
-$0.0038-97.44%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 38.90K | 52.80K | 118.10K | 94.50K | 65.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 38.90K | 52.80K | 118.10K | 94.50K | 65.50K |
| Cost of Revenue | 164.90K | 180.30K | 220.00K | 404.00K | 225.50K |
| Gross Profit | -126.00K | -127.40K | -101.90K | -309.50K | -159.90K |
| SG&A Expenses | 174.50K | 252.60K | 204.20K | 669.50K | 711.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 339.40K | 432.90K | 424.30K | 1.07M | 936.60K |
| Operating Income | -300.50K | -380.00K | -306.10K | -979.10K | -871.10K |
| Income Before Tax | 263.80K | -485.90K | -486.60K | -1.45M | -908.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 263.80K | -485.90K | -486.60K | -1.45M | -908.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 263.80K | -485.90K | -486.60K | -1.45M | -908.10K |
| EBIT | -300.50K | -380.00K | -306.10K | -979.10K | -871.10K |
| EBITDA | -299.80K | -379.10K | -305.00K | -951.90K | -869.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 162.27M | 138.83M | 134.04M | 130.52M | 130.49M |
| Average Diluted Shares Outstanding | 162.27M | 138.83M | 134.04M | 130.52M | 130.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |